ABL Diagnostics Société anonyme (EPA:ABLD)
France · Delayed Price · Currency is EUR 3.100
-0.240 (-7.19%)
Jun 3, 2026, 5:18 PM CET
EPA:ABLD Market Cap
EPA:ABLD has a market cap or net worth of €49.82 million as of June 3, 2026. Its market cap has decreased by -42.75% in one year.
Market Cap
49.82M
Enterprise Value
50.75M
Revenue
7.97M
Ranking
n/a
PE Ratio
51.67
Stock Price
€3.10
Market Cap Chart
Since November 17, 2000, EPA:ABLD's market cap has increased from 2.51M to 49.82M, an increase of 1,886.17%. That is a compound annual growth rate of 12.41%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Jun 2, 2026 | 53.67M | 11.03% |
| Dec 31, 2025 | 48.34M | 21.95% |
| Dec 31, 2024 | 39.64M | -74.64% |
| Dec 29, 2023 | 156.30M | 3,819.50% |
| Dec 30, 2021 | 3.99M | 34.75% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Sanofi | 90.36B |
| EssilorLuxottica Société anonyme | 80.52B |
| Sartorius Stedim Biotech | 17.33B |
| Ipsen | 12.86B |
| Klea Holding | 60.42M |
| MaaT Pharma | 53.70M |
| THX Pharma Société Anonyme | 51.60M |
| Theraclion | 50.88M |